Evidence map›Paper›PMID 38717330›Full record

ArticleAmerican journal of epidemiology2025

Data-driven simulations to assess the impact of study imperfections in time-to-event analyses.

Michal Abrahamowicz, Marie-Eve Beauchamp, Anne-Laure Boulesteix, Tim P Morris, Willi Sauerbrei, Jay S Kaufman, On Behalf Of The Stratos Simulation Panel

Abstract read
In one paragraph

Article in American journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michal AbrahamowiczDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC H3A 1Y7, Canada.ORCID 0000-0002-3172-3952
Marie-Eve BeauchampCentre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, QC H4A 3S5, Canada.ORCID 0000-0001-9488-0157
Anne-Laure BoulesteixInstitute for Medical Information Processing, Biometry, and Epidemiology, Faculty of Medicine, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.ORCID 0000-0002-2729-0947
Tim P MorrisMRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, United Kingdom.ORCID 0000-0001-5850-3610
Willi SauerbreiInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-6792-4123
Jay S KaufmanDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC H3A 1Y7, Canada.ORCID 0000-0003-1606-401X
On Behalf Of The Stratos Simulation Panel

Funding

CIHR PJT-180634German Research Foundation SA580/10-1Medical Research Council MC_UU_00004/07
6 · The paper itself

Abstract

Quantitative bias analysis (QBA) permits assessment of the expected impact of various imperfections of the available data on the results and conclusions of a particular real-world study. This article extends QBA methodology to multivariable time-to-event analyses with right-censored endpoints, possibly including time-varying exposures or covariates. The proposed approach employs data-driven simulations, which preserve important features of the data at hand while offering flexibility in controlling the parameters and assumptions that may affect the results. First, the steps required to perform data-driven simulations are described, and then two examples of real-world time-to-event analyses illustrate their implementation and the insights they may offer. The first example focuses on the omission of an important time-invariant predictor of the outcome in a prognostic study of cancer mortality, and permits separating the expected impact of confounding bias from noncollapsibility. The second example assesses how imprecise timing of an interval-censored event-ascertained only at sparse times of clinic visits-affects its estimated association with a time-varying drug exposure. The simulation results also provide a basis for comparing the performance of two alternative strategies for imputing the unknown event times in this setting. The R scripts that permit the reproduction of our examples are provided.

Indexed as

Computer SimulationBiasData Interpretation, StatisticalHumansModels, StatisticalNeoplasmsTime Factorsinterval censoringnoncollapsibilityquantitative bias analysissensitivity analysessimulationssurvival analysistime-varying exposure

Identifiers

PMID38717330
PMCPMC7617302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.